CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
The NeuMoDx 288 and NeuMoDx 96 offer 13 CE-IVD-marked assays for infectious diseases, including a dedicated COVID-19 test, which has received FDA emergency use authorization. A multiplex test for influenza, respiratory syncytial virus, and SARS-CoV-2 is scheduled for launch in the fourth quarter of this year.
Pages: 1 2